ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,630Medicare Part D Prescriptions Filled, Including Refills

Rank: 749 out of 2170

$366K Total Retail Price of All Prescriptions

Rank: 771 out of 2170

450 Patients Receiving at Least One Drug in Part D
58%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 450 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

26% of this provider’s 450 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 3,927 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
LISINOPRIL 283 170 1 3
SIMVASTATIN 267 218 2 1
OMEPRAZOLE 232 129 3 2
AMLODIPINE BESYLATE 220 145 4 4
FUROSEMIDE 218 131 5 6
HYDROCHLOROTHIAZIDE 153 99 6 9
METOPROLOL TARTRATE 138 76 7 10
TRAMADOL HCL 115 61 8 18
POTASSIUM CHLORIDE 94 56 9 16
METFORMIN HCL 92 43 10 8
HYDROCODONE-ACETAMINOPHEN 90 37 S3 11 7
GLIMEPIRIDE 87 39 12 31
ACETAMINOPHEN-CODEINE 86 50 S3 13 206
METFORMIN HCL ER 84 44 14 35
LISINOPRIL-HYDROCHLOROTHIAZIDE 84 55 14 20
LEVOTHYROXINE SODIUM 82 52 16 5
SULFAMETHOXAZOLE-TRIMETHOPRIM 79 40 17 95
CRESTOR 79 43 17 24
ATENOLOL 79 65 17 23
PRAVASTATIN SODIUM 77 48 20 11
PROMETHAZINE HCL 75 36 R 21 70
ZOLPIDEM TARTRATE 74 45 22 17
NEXIUM 74 22 22 22
CIPROFLOXACIN HCL 64 33 24 69
DIOVAN 62 52 25 53
CYCLOBENZAPRINE HCL 62 0 R 25 52
SYNTHROID 60 35 27 27
ATORVASTATIN CALCIUM 58 39 28 12
PLAVIX 57 50 29 58
FLUTICASONE PROPIONATE 57 30 29 30
WARFARIN SODIUM 56 41 31 15
METOPROLOL SUCCINATE 55 45 32 13
DIOVAN HCT 52 35 33 76
CARVEDILOL 51 29 34 26
ALLOPURINOL 51 45 34 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 13, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.